Back to Search
Start Over
Vertex Pharmaceuticals price target lowered by $10 at Oppenheimer, here's why
- Source :
- The Fly. October 30, 2024
- Publication Year :
- 2024
-
Abstract
- Oppenheimer lowered the firm's price target on Vertex Pharmaceuticals to $540 from $550 and keeps an Outperform rating on the shares ahead of quarterly results. The firm is updating its [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- The Fly
- Publication Type :
- Periodical
- Accession number :
- edsgcl.814201126